1155 - Short vs. Long Symptom Duration Prior to Remdesivir for Hospitalized Patients with COVID-19

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

MA

Meagan L. Adamsick, PharmD

Clinical Pharmacist - Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts, United States
JH

Joanne Huang, PharmD, BCIDP

Massachusetts General Hospital
Boston, Massachusetts, United States
Marisa Winkler, MD, PhD

Medical Microbiology Fellow
Massachusetts General Hospital
Boston, Massachusetts, United States
MG

Musie Ghebremichael, PhD

The Ragon Institute of MGH, MIT and Harvard
Cambridge, Massachusetts, United States
FC

Fiona Cheung, PharmD

Massachusetts General Hospital
Boston, Massachusetts, United States
BP

Bryan Polsonetti, PharmD

Gilead Sciences
Foster City, California, United States
Essy Mozaffari, PharmD, MPH, MBA

Senior Director
Gilead Sciences
Foster, California, United States
LC

Linda Chen, MPH

Gilead Sciences
fos, California, United States
BJ

Boris Juelg, MD

Massachusetts General Hospital
Boston, Massachusetts, United States
EH

Elizabeth Hohmann, MD

Massachusetts General Hospital
Boston, Massachusetts, United States